SLC39A14 and renal cell carcinoma: In renal cell carcinoma (RCC) tissues, like in NPC, the mRNA expression of SLC39A14 was significantly enhanced; inhibiting SLC39A14 might impair the migration, invasion, proliferation, and epithelial-mesenchymal transition (EMT) of RCC cells [47].